These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10715517)
1. Biochemical analysis of HLA class I subunits expression in breast cancer tissues. Pistillo MP; Nicolò G; Salvi S; Capanni P; Perdelli L; Pasciucco G; Ferrara GB Hum Immunol; 2000 Apr; 61(4):397-407. PubMed ID: 10715517 [TBL] [Abstract][Full Text] [Related]
2. Investigation of HLA class I downregulation in breast cancer by RT-PCR. Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of HLA class I antigens in breast cancer: association with prognosis. Gudmundsdóttir I; Gunnlaugur Jónasson J; Sigurdsson H; Olafsdóttir K; Tryggvadóttir L; Ogmundsdóttir HM Int J Cancer; 2000 Nov; 89(6):500-5. PubMed ID: 11102894 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis. Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914 [TBL] [Abstract][Full Text] [Related]
5. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333 [TBL] [Abstract][Full Text] [Related]
6. HLA class I molecules expression: evaluation of different immunocytochemical methods in malignant lesions. Facoetti A; Capelli E; Nano R Anticancer Res; 2001; 21(4A):2435-40. PubMed ID: 11724304 [TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases. Maiorana A; Cesinaro AM; Fano RA; Collina G Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen G expression in breast cancer: role in immunosuppression. Elliott RL; Jiang XP; Phillips JT; Barnett BG; Head JF Cancer Biother Radiopharm; 2011 Apr; 26(2):153-7. PubMed ID: 21510769 [TBL] [Abstract][Full Text] [Related]
9. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081 [TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. Perosa F; Luccarelli G; Prete M; Favoino E; Ferrone S; Dammacco F J Immunol; 2003 Aug; 171(4):1918-26. PubMed ID: 12902494 [TBL] [Abstract][Full Text] [Related]
11. Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer. Morabito A; Dozin B; Salvi S; Pasciucco G; Balbi G; Laurent S; Pastorino S; Carli F; Truini M; Bruzzi P; Del Mastro L; Pistillo MP Hum Immunol; 2009 Jul; 70(7):492-5. PubMed ID: 19410618 [TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Kleinberg L; Flørenes VA; Skrede M; Dong HP; Nielsen S; McMaster MT; Nesland JM; Shih IeM; Davidson B Virchows Arch; 2006 Jul; 449(1):31-9. PubMed ID: 16541284 [TBL] [Abstract][Full Text] [Related]
13. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139 [TBL] [Abstract][Full Text] [Related]
14. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Kaklamanis L; Leek R; Koukourakis M; Gatter KC; Harris AL Cancer Res; 1995 Nov; 55(22):5191-4. PubMed ID: 7585572 [TBL] [Abstract][Full Text] [Related]
15. Analysis of HLA-E expression in human tumors. Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909 [TBL] [Abstract][Full Text] [Related]
16. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes. Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452 [TBL] [Abstract][Full Text] [Related]
17. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines. Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515 [TBL] [Abstract][Full Text] [Related]
18. [Tissue expression of antigenic recognition and intercellular adhesion molecules in chronic viral hepatitis]. García Monzón C; García Buey L; García Sánchez A; de Castro Marinas M; Muñoz Gómez R; Pajares JM; González Mateos F; Moreno Otero R Rev Esp Enferm Dig; 1993 Nov; 84(5):301-9. PubMed ID: 7508239 [TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880 [TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Park GM; Lee S; Park B; Kim E; Shin J; Cho K; Ahn K Biochem Biophys Res Commun; 2004 Jan; 313(3):606-11. PubMed ID: 14697234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]